ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 79 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,348,329 | -47.1% | 4,020,401 | -5.0% | 0.00% | 0.0% |
Q2 2023 | $40,324,995 | -20.3% | 4,231,374 | -8.0% | 0.00% | 0.0% |
Q1 2023 | $50,580,992 | -34.5% | 4,598,272 | -11.8% | 0.00% | -50.0% |
Q4 2022 | $77,171,020 | -20.5% | 5,214,258 | +2.6% | 0.00% | -33.3% |
Q3 2022 | $97,110,000 | -0.5% | 5,081,744 | +11.0% | 0.00% | 0.0% |
Q2 2022 | $97,561,000 | +17.4% | 4,578,153 | +6.1% | 0.00% | +50.0% |
Q1 2022 | $83,124,000 | -7.1% | 4,315,802 | +0.0% | 0.00% | 0.0% |
Q4 2021 | $89,471,000 | -10.7% | 4,313,864 | +2.8% | 0.00% | -33.3% |
Q3 2021 | $100,241,000 | -13.5% | 4,195,926 | -1.2% | 0.00% | 0.0% |
Q2 2021 | $115,945,000 | -4.6% | 4,248,620 | +1.1% | 0.00% | -25.0% |
Q1 2021 | $121,562,000 | +49.3% | 4,201,959 | +45.1% | 0.00% | +33.3% |
Q4 2020 | $81,437,000 | +35.2% | 2,895,054 | +40.8% | 0.00% | +50.0% |
Q3 2020 | $60,253,000 | +27.2% | 2,056,386 | +31.3% | 0.00% | 0.0% |
Q2 2020 | $47,372,000 | +83.7% | 1,566,574 | +81.0% | 0.00% | +100.0% |
Q1 2020 | $25,786,000 | – | 865,309 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Frazier Life Sciences Management, L.P. | 8,684,232 | $46,113,272 | 3.06% |
Pivotal bioVenture Partners Investment Advisor LLC | 1,105,309 | $5,869,191 | 2.34% |
Bain Capital Life Sciences Investors, LLC | 3,000,000 | $15,930,000 | 1.78% |
Sio Capital Management, LLC | 635,969 | $3,376,995 | 1.04% |
Rubric Capital Management LP | 5,034,530 | $26,733,354 | 1.00% |
Tejara Capital Ltd | 309,179 | $1,641,740 | 0.93% |
AlphaCentric Advisors LLC | 165,000 | $876,150 | 0.50% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,135,227 | $6,028,055 | 0.33% |
Orbimed Advisors | 1,914,479 | $10,165,883 | 0.22% |
Two Seas Capital LP | 164,807 | $875,125 | 0.18% |